Definium Therapeutics, Inc. (DFTX)
29.12
-0.26
(-0.88%)
USD |
NASDAQ |
Nov 18, 16:00
28.71
-0.41
(-1.41%)
After-Hours: 18:13
Definium Therapeutics Price : 29.12 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 30.05 | 30.52 | 28.44 | 29.38 | 1.937M |
| Nov 16, 2026 | 31.47 | 32.42 | 30.04 | 30.16 | 1.132M |
| Nov 13, 2026 | 32.70 | 32.70 | 31.47 | 32.08 | 778188.0 |
| Nov 12, 2026 | 34.04 | 34.04 | 32.75 | 33.00 | 1.203M |
| Nov 11, 2026 | 35.23 | 35.23 | 33.91 | 34.47 | 1.442M |
| Nov 10, 2026 | 34.45 | 35.97 | 33.78 | 34.64 | 1.296M |
| Nov 09, 2026 | 33.84 | 35.44 | 33.35 | 35.39 | 1.414M |
| Nov 06, 2026 | 31.23 | 33.42 | 30.91 | 33.27 | 1.278M |
| Nov 05, 2026 | 32.26 | 32.33 | 30.17 | 30.36 | 1.916M |
| Nov 04, 2026 | 33.48 | 33.87 | 31.70 | 32.70 | 1.414M |
| Nov 03, 2026 | 32.99 | 34.62 | 32.73 | 33.41 | 1.724M |
| Nov 02, 2026 | 36.51 | 36.84 | 31.61 | 32.47 | 3.646M |
| Oct 30, 2026 | 37.24 | 37.95 | 35.87 | 36.33 | 1.077M |
| Oct 29, 2026 | 38.32 | 39.14 | 37.79 | 37.96 | 1.420M |
| Oct 28, 2026 | 36.87 | 38.43 | 36.76 | 38.10 | 1.678M |
| Oct 27, 2026 | 35.42 | 37.61 | 35.18 | 37.08 | 1.282M |
| Oct 26, 2026 | 35.60 | 36.35 | 34.74 | 35.68 | 1.054M |
| Oct 23, 2026 | 36.01 | 36.12 | 35.09 | 35.67 | 1.755M |
| Oct 22, 2026 | 35.29 | 36.23 | 35.09 | 36.00 | 2.093M |
| Oct 21, 2026 | 35.46 | 36.34 | 35.04 | 35.49 | 2.906M |
| Oct 20, 2026 | 32.99 | 35.58 | 32.78 | 35.09 | 1.746M |
| Oct 19, 2026 | 32.28 | 33.30 | 32.23 | 32.97 | 1.736M |
| Oct 16, 2026 | 34.07 | 34.15 | 32.02 | 32.10 | 1.935M |
| Oct 15, 2026 | 34.23 | 34.79 | 33.92 | 34.26 | 1.748M |
| Oct 14, 2026 | 34.20 | 34.91 | 33.65 | 34.24 | 1.762M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enliven Therapeutics, Inc. | 44.92 |
| Cocrystal Pharma, Inc. | 0.97 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Arvinas, Inc. | 6.77 |
Price Related Metrics
| PEG Ratio | -0.1791 |
| Price to Book Value | 4.118 |
| Earnings Yield | -10.41% |
| Market Cap | 3.986B |
| PEGY Ratio | -0.1791 |